Struma Ovarii with Papillary Thyroid Carcinoma and Metastasis to the Appendix: A Case Report and Literature Review
- PMID: 37753203
- PMCID: PMC10519172
- DOI: 10.2147/IMCRJ.S432333
Struma Ovarii with Papillary Thyroid Carcinoma and Metastasis to the Appendix: A Case Report and Literature Review
Abstract
Struma ovarii is an infrequent type of teratoma arising from the ovary accounting for only 2% of all ovarian teratomas. These tumors have a benign biology with rare malignant transformation in about 3% of cases. The most common malignant transformation that arises from struma ovarii is papillary thyroid carcinoma. These neoplasms act in the same way as those arising from the thyroid gland, but due to the rarity of their occurrence there is still a debate over therapeutic options. We present a case of a 41-year-old Ethiopian Para IX woman presented with abdominal swelling for four years, accompanied by dull pain, satiety, and weight loss. Her vital signs were normal, and her abdominal examination revealed a large abdominopelvic mass. Her CA-125 was elevated, and her blood count, organ function tests, and serum electrolyte levels were normal. Abdominal ultrasound revealed a complex abdominopelvic mass with cystic and solid components, possibly ovarian teratoma. The patient underwent surgery, revealing a 14 by 10 cm right ovarian mass and a 3×3 cm appendiceal mass. Subsequently, total abdominal hysterectomy, bilateral salpingo-oophorectomy, total omentectomy, and appendectomy was done. Histopathologic evaluation revealed follicular proliferation of enlarged cells, with no papillary growth pattern. The case was diagnosed as malignant struma ovarii, a follicular variant of papillary thyroid carcinoma (FVPTC) with secondary deposits on the appendix. A complete thyroidectomy was done after the histopathology diagnosis. Malignant struma ovarii is rare making it challenging to treat since there are no established prognosticating histopathologic or clinical characteristics. The tumor size and metastasis determine the surgical treatment scope. Large-scale investigations are essential for prognostication and treatment options considering pathologic traits.
Keywords: appendix; malignant; metastasis; papillary carcinoma; struma ovarii; teratoma.
© 2023 Abera et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures







Similar articles
-
Follicular Thyroid Carcinoma Arising from the Struma Ovarii Coexisting with Papillary Thyroid Carcinoma, Hashimoto's Thyroiditis and Polycystic Ovarian Syndrome-a Case Report and Literature Review.Int J Womens Health. 2024 Jul 1;16:1187-1198. doi: 10.2147/IJWH.S454119. eCollection 2024. Int J Womens Health. 2024. PMID: 38974515 Free PMC article.
-
RET/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: a case report and review of the literature.Thyroid Res. 2023 Sep 27;16(1):39. doi: 10.1186/s13044-023-00181-5. Thyroid Res. 2023. PMID: 37759238 Free PMC article.
-
Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.J Med Case Rep. 2022 Sep 30;16(1):348. doi: 10.1186/s13256-022-03590-6. J Med Case Rep. 2022. PMID: 36176008 Free PMC article.
-
Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature.Gynecol Oncol. 2004 Sep;94(3):835-9. doi: 10.1016/j.ygyno.2004.06.003. Gynecol Oncol. 2004. PMID: 15350384 Review.
-
Malignant struma ovarii--a case report and review of the literature.Gynecol Obstet Invest. 2008;65(2):104-7. doi: 10.1159/000108654. Epub 2007 Sep 21. Gynecol Obstet Invest. 2008. PMID: 17890867 Review.
Cited by
-
Struma ovarii-diagnostic and treatment strategy: a case report.J Med Case Rep. 2025 Jun 19;19(1):285. doi: 10.1186/s13256-025-05152-y. J Med Case Rep. 2025. PMID: 40537851 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous